These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma. Gil L; Kazmierczak M; Kroll-Balcerzak R; Komarnicki M Med Oncol; 2014 May; 31(5):944. PubMed ID: 24752517 [TBL] [Abstract][Full Text] [Related]
18. Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report. Renfrow JJ; Detroye A; Chan M; Tatter S; Ellis T; McMullen K; Johnson A; Mott R; Lesser GJ J Neurooncol; 2012 May; 107(3):659-63. PubMed ID: 22249693 [TBL] [Abstract][Full Text] [Related]
19. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia. Kath R; Blumenstengel K; Fricke HJ; Höffken K J Cancer Res Clin Oncol; 2001 Jan; 127(1):48-54. PubMed ID: 11206271 [TBL] [Abstract][Full Text] [Related]
20. Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. Zinzani PL; Derenzini E; Pellegrini C; Celli M; Broccoli A; Argnani L Br J Haematol; 2013 Dec; 163(5):681-3. PubMed ID: 24032977 [No Abstract] [Full Text] [Related] [Next] [New Search]